Post Profile






Study compares CV risk reduction of statin vs nonstatin therapies used for lowering LDL-C

Scientists evaluated the association between lowering low-density lipoprotein cholesterol (LDL-C) and relative cardiovascular risk reduction across different statin and nonstatin therapies.
read more

share

Related Posts


Statins Aren’t the Only Way to Lower Cholesterol

Health : Time: Healthland

Statins are the most prescribed and best-selling drugs around, but the latest study says other strategies may lower cholesterol just as well

Use Of Drugs To Block "Niacin Flush" In Heart Patients Questioned

Health : Medical News Today

Niacin, or vitamin B3, is the one approved drug that elevates "good" cholesterol (high density lipoprotein, HDL) while depressing "bad" cholesterol (low density lipoprotein, LDL), and has thereby attracted much attention from patien...

Combo therapy with lower intensity statin may be an alternative to higher-intensity monotherapy for some patients

Health : Medical News Today

The recent American College of Cardiology and American Heart Association cholesterol guidelines recommend initiating moderate or high-intensity statin monotherapy for patients with low-density lipoprotein (LDL) cholesterol levels of...

Medical News Today: Are statins the best cholesterol-lowering drug? Study investigates

Health : Medical News Today

Researchers have reviewed both statin and nonstatin therapies in an attempt to determine how they impact cholesterol levels and cardiovascular risk.

Study Compares CV Risk Reduction of Statin vs Nonstatin Therapies Used for Lowering LDL-C

Health : Newswise Medical News

In a study appearing in the September 27 issue of JAMA, Marc S. Sabatine, M.D., M.P.H., of Brigham and Women's Hospital, Harvard Medical School, Boston, and colleagues evaluated the association between lowering low-density lipoprote...

Comments


Copyright © 2016 Regator, LLC